HOXA9 and cancer: We analyzed publicly available gene expression data of pre-leukemic Hoxa9 (H9)- and leukemic H9M-overexpressing murine bone marrow cells with the aim to functionally interrogate the most highly upregulated genes and those that cluster in the leading edge of cancer-associated gene set enrichment analyses (GSEA) [11].